Beruflich Dokumente
Kultur Dokumente
References
Iranian Council for graduate Medical Education. Board and pre-board Exam questions for OBS and Gyn .2001-2006 Panda S . IUGR. Department of Obstetrics & Gynecology Medical College of India 2002 Pritchard JA, MacDonald PC, Gant NF. Williams Obstetrics. 22nd ed. New York, NY: McGraw-Hill; 2005. Tan T and Yeo G. IUGR. Current Opinion in Obstetrics and Gynecology 2005, 17: 135142
emedicine e-journal:
Butler J. postterm delivery. emedicine. June 19. 2006 Gaufberg S. Abruptio placenta. emedicine. Aug 29. 2006 Gibson P. HTN in Pregnancy. emedicine. DEC 13 2007 Hernandez E . GTN. emedicine. Jan 26, 2007 Marinnan G. Placenta Previa. emedicine. Aug 26. 2005 Ross M. preterm. emedicine. 31 may 2007
Pictures and material of multiple pregnancy are adapted with permission from:
Zach T. multiple pregnancy.emedicine. Oct 2. 2007
HTN in Pregnancy
classification
Hypertension is the most common medical problem encountered during pregnancy, complicating 2-3% of pregnancies. HTN is classified into 4 categories 1) chronic hypertension, 2) preeclampsia-eclampsia, 3) preeclampsia superimposed on chronic hypertension 4) gestational hypertension (transient hypertension of pregnancy or chronic hypertension identified in the latter half of pregnancy).
Chronic HTN
blood pressure exceeding 140/90 mm Hg before pregnancy or before 20 weeks' gestation. It persists after 12 wks postpartum.
Gestational Age
New-onset or worsening hypertension after 20 weeks' gestation should lead to a careful evaluation for manifestations of preeclampsia. The diagnosis of severe hypertension or preeclampsia in the first or early second trimester necessitates exclusion of GTD and/or molar pregnancy.
BP measurement
Blood pressure should be measured in the sitting position, with the cuff at the level of the heart. Women should be allowed to sit quietly for 5-10 minutes before each blood pressure measurement. Korotkoff sounds I (the first sound) and V (the disappearance of sound) should be used to denote the systolic blood pressure (SBP) and DBP, respectively.
IUGR
Pulmonary edema
Absent
Absent
Present
present
CBC
Platelet counts less than 100,000/L suggest preeclampsia or ITP. Hemoglobin levels greater than 13 g/dL suggest hemoconcentration. Low Hbg levels may be due to microangiopathic hemolysis or iron deficiency.
Proteinurea
Trace levels to +1 proteinuria are acceptable, but levels of +2 or greater are abnormal and should be quantified with a 24-hour urine collection or spot urine protein:creatinine ratio. In a 24-hour urine collection, the reference range for protein excretion in pregnancy is up to 300 mg/d.
Protein:Cr ratio
Creatinine clearance increases approximately 50% during pregnancy, and levels less than 100 mL/min suggest renal dysfunction that is either chronic or due to preeclampsia.
protein:Cr ratios appear to be more accurate than urinalysis, although an abnormal result should still be confirmed with a 24-hour urine collection.
Coagulation tests
LDH, bilirubin, haptoglobin, fibrinogen, D-dimers If: PT/INR/aPTT results are abnormal, thrombocytopenia is present, the hemoglobin level is dropping
Fetal Monitoring Alternate a biophysical profile with a fetal NST twice each week. Ask for Serial fetal ultrasound starting at 18 weeks.
Methyldopa (Aldomet)
Centrally acting antihypertensive agent widely considered the first-line agent for treatment of hypertension during pregnancy.
Hydralazine (Apresoline) Intravenous form is useful when treating severe hypertension due to preeclampsia/eclampsia.
10-20 mg/dose IV q4-6h prn initial; increase to 40 mg per dose prn BP >170/110 mm Hg: 0.1-0.2 mg/kg/dose IV q4-6h prn; not to exceed 20 mg or 1.7-3.5 mg/kg/d IV divided q4-6h
MgSO4 (4 gr) in 200cc DW5% in 20 min then 10 gr(1/2) im in each buttock then 5 gr im q4h If platelet is below 100000 then 20 gr in 1000cc infused in 100cc/hrs (check of I/O, RR, DTR, prep CPR set with 2 gr 20% MgSO4 ready) +Amp Dexa 6 mg bid for 4 doses OTHER: Control of vital sign q15 min , control of FHR, fix foley,
Preterm Pregnancy
Definition
Preterm labor is defined as the presence of uterine contractions of sufficient frequency and intensity to effect progressive effacement and dilation of the cervix prior to term gestation (between 20 and 37 wk). It is the leading cause of neonatal mortality.
salivary estriol : DHEA increases before the onset of labor. This results in an increase of maternal estriol.
FFN is a basement membrane protein that helps bind placental membranes to the decidua. FFN has a predictive value in identifying patients who will or will not deliver within the subsequent 1-2 weeks.
A short cervical length in the early or late second trimester has been associated with a markedly increased risk of preterm labor and delivery.
Contraindication to tocolysis
1-Fetal growth restriction 2-Oligohydramnios 3-Nonreactive NST,Positive CST 4-Absent or reversed diastolic flow upon Doppler examination of umbilical blood flow 5-Repetitive severe variable decelerations 6-Significant vaginal bleeding consistent with abruption.
Chorioamnionitis Order
General: condition/position/diet=NPO Lab: CBC diff, MP, WW, B/C X2, U/A , U/C,CXR,BUN/Cr IV : 1000cc Ringer +10 units of oxytocin start at 2 drops /min, add 2 drops every 15 min if FHR and contractions are normal
Amp ampicillin 2gr iv qid +gentamicin im 80mg stat then 60 mg TDS AMP clindamycin 900 mg iv TDS for allergic women to penicillin(continue antibiotics after delivery until the mother is a febrile
OTHER: Control of vital sign q4hrs, Inform if LP, leakage, VB, ab VS or FHR
Postterm
Definition of postterm
Postterm pregnancies define pregnancies extending up to or after 42 weeks. The reported frequency is 3-12%.
Cause of postterm P.
The most frequent cause of postterm pregnancy is inaccurate dating criteria primiparity, prior postterm pregnancy, male gender of the fetus, genetic factors
Risks of postterm P
Macrosomia complications like shoulder dystocia, CPD and Maternal risks like an increase in labor dystocia, perineal injuries, and cesarean deliveries. dysmaturity syndrome: affects 20% of postterm fetuses and is thought to be caused by chronic uteroplacental insufficiency resulting in oligohydramnios, meconium aspiration, and reversible neonatal complications.
surveillance
NST and AFI 2 times per week for pregnancies continuing past 41 weeks.
Definition
Intrauterine growth restriction (IUGR)
occurs when the unborn baby is at or below the 10th weight percentile for his or her age (in weeks). The fetus is affected by a pathologic restriction in its ability to grow.
Classification
Symmetricl
the baby's head and body are proportionately small. may occur when the fetus experiences a problem during early development.
Asymmetrical
baby's brain is abnormally large when compared to the liver. may occur when the fetus experiences a problem during later development
Etiology of IUGR
Idiopathic- In a majority of cases (40%)
Birth defect (cardiovascular, renal, anencephally, limb defect, etc). Chromosome defect(trisomy-18 (Edwards
syndrome),21(Downs syndrome), 16, 13, xo (turners syndrome.)
Primary disorder of bone or cartilage. Chronic lack of oxygen during development (hypoxia). Developed outside of the uterus. Placenta or umbilical cord defects.
Placental Factors
Uteroplacental insufficiency: Improper / inadequate trophoblastic invasion and placentation in the first trimester. Lateral insertion of placenta. Reduced maternal blood flow to the placental bed.
Screening:
US fetal biometry: HC- BPD- AC
Uterine Doppler studies (Doppler Velocimetry): bilateral notches and a mean resistance index of at least 0.55 Or Unilateral notches and a mean resistance index of at least 0.65 at 20 weeks. Biochemistry: CRH level at 33 weeks
Neonatal Diagnosis
Low ponderal index (Wt./Fl). Decreased subcutaneous fat. Presence / appearance of
Hypoglycemia, Hyperbilirubinemia, Necrotizing enterocolitis, Hyper viscosity syndrome
Prevention
Strong evidence of benefit only for the following interventions:
balanced protein/energy supplementation, strategies to reduce maternal smoking, antibiotic administration to prevent urinary tract infections antimalarial prophylaxis.
Surveillance
Non-Stress Test, Amniotic Fluid Index, Doppler of the Umbilical Artery Biophysical Profile
Surveillance
The current recommendations are that if the AFI decreases below 5 after 35 weeks, then delivery should occur.
Treatment
Bed rest Aspirin before 20 wk GA Nutritional supplementation: zinc , fish oil, hormones Oxygen therapy.
For monochorionic twins photocoagulation of anastomoses or diathermy in cases of TTTS and AAA
abruptio
Definition
Abruptio placentae (ie, placental abruption) refers to separation of the normally located placenta after the 20th week of gestation. Abruptio placentae occurs in about 1% of all pregnancies.
Classification of abruptio
extent of separation (ie, partial vs complete) location of separation (ie, marginal vs central) Clinical
classification
Class VB Uterus BP-HR coagulopathy tenderness Fetal distress
0 1 2(I=27%)
--------mild Modsevere
NL NL Tilt +
3(I=24%)
Mildsevere
tetanic
Causes1
Maternal HTN(44% of all cases) Maternal trauma Cigarette smoking Alcohol consumption Cocaine use Advanced maternal age
causes2
Short umbilical cord Sudden decompression of the uterus (eg, PROM, delivery of first twin) Retroplacental fibromyoma postamniocentesis Idiopathic (probable abnormalities of uterine blood vessels and decidua)
Imaging Studies
Ultrasonography is not very useful in diagnosing placental abruption.
Retroplacental hematoma may be recognized in 225% of all abruptions. Recognition of retroplacental hematoma depends on the degree of hematoma and on the operator's skill level.
Placenta Previa
subtypes
(1) complete or total: the placenta covers 360 of the internal cervical os; (2) incomplete or partial: 0-360 of the internal cervical os is covered by placental tissue; (3) marginal: the placental tissue does not cover the internal cervical os; (4) low lying: the edge of the placenta lies abnormally close to but does not abut the internal cervical os.
Risk factors
prior placenta previa, prior cesarean delivery, increased maternal age, large placentae (eg, multiple gestations or erythroblastosis), maternal history of smoking.
Frequency
1 in 200 deliveries
Vaginal Bleeding
painless vaginal bleeding during the second half of pregnancy (70%). It can occur without an inciting cause, although pelvic examination, intercourse, or labor may provoke it. The average gestational age at presentation is 32 weeks. Hemorrhage recurs, and, in nearly all cases, it is more severe the second time.
management
Patients are treated expectantly, with: volume replacement, transfusions, tocolytics, emergent cesarean delivery Without endangering the life of the mother, all attempts are made to delay delivery until the fetal lungs mature.
Preferred Examination
Physical examination should be performed only with a fetus that has achieved pulmonary maturity and only in a fully staffed operating room.
Preferred examination
TA sonography is the test of choice to confirm placenta previa. When the internal cervical os cannot be visualized or when the results are inconclusive, transperineal or transvaginal sonography is recommended as an adjunct. No increased risk of hemorrhage has been associated with transvaginal or transperineal sonography in this clinical setting.
Class 1 Blood Loss Volume (mls) in adult Blood Loss % Circ. blood volume Systolic Blood Pressure Diastolic Blood Pressure
Class 2
Class 3
Class 4
750mls
800 - 1500mls
1500 - 2000mls
>2000mls
<15%
15 - 30%
30 - 40%
>40%
No change
Normal
Reduced
No change
Raised
Reduced
100 - 120
120 (thready)
1000 mls
o r
1500 mls
o r
2000 mls
o r
Multiple pregnancy
Pictures and material of multiple pregnancy are adapted from: Zach T. multiple pregnancy. emedicine. Oct 2. 2007 with permission
pathophysiology1
Dizygotic twins(fraternal) are produced when 2 sperm fertilize 2 ova. Separate amnions, chorions, and placentas are formed in dizygotic twins. The placentas in dizygotic twins may fuse if the implantation sites are proximate. The fused placentas can be easily separated after birth. Monozygotic twins (Identical)develop when a single fertilized ovum splits during the first 2 weeks after conception. An early splitting (ie, within the first 2 d after fertilization-30%) of monozygotic twins produces separate chorions and amnions. These dichorionic twins have different placentas that can be separate or fused.
Diamniotic/dichorionic placentation
pathophysiology2
Later splitting (ie, 3-8 d after fertilization) results in monochorionic/diamniotic placentation . Approximately 70% of monozygotic twins are monochorionic/diamniotic.
Diamniotic/monochorionic placentation
pathophysiology3
If splitting occurs even later (ie, during 9-12 d after fertilization), monochorionic/monoamniotic placentation occurs . Monochorionic/monoamniotic twins are rare; only 1% of monozygotic twins have this form of placentation.
Monoamniotic/monoamniotic placentation
pathophysiology4
Monochorionic/monoamniotic twins have a common placenta with vascular communications between the 2 circulations.
pathophysiology5
Trizygotic triplets occur when 3 sperm fertilize 3 ova. Dizygotic triplets develop from one set of monozygotic cotriplets and a third cotriplet derived from a different zygote. Finally, 2 consecutive zygotic splittings with one split results in a vanished fetus and monozygotic triplets.
Frequency
The birth rate of monozygotic twins is constant worldwide (approximately 4 per 1000 births). Birth rates of dizygotic twins vary by race. (Highest in Africans and lowerest in Asians)
mortality
low birth weight infants( due to prematurity and (IUGR) congenital anomalies, placenta previa, abruptio placenta, preeclampsia, cord accidents, malpresentations, asphyxia/perinatal depression, group B streptococcal (GBS) infections, hyaline membrane disease (HMD), TTTS.
History
excessive weight gain, hyperemesis gravidarum, sensation of more than one moving fetus use of ovulation-inducing drugs family history of dizygotic twins
TRAP
Twin reversed arterial perfusion (TRAP) sequence occurs when an acardiac twin receives all of the blood supply from the normal "pump" twin. This only occurs in monochorionic twins.
TTTS
Occurs in monochorionic/monoamniotic or monochorionic/diamniotic twins. Vascular anastomoses in the monochorionic placenta result in transfusion of blood from one twin (ie, donor) to the other twin (ie, recipient). Polyhydramnios develops in the sac of the recipient twin and oligohydramnios develops in the sac of the donor twin.
Conjoined twins
Incomplete late division of monozygotic twins produces conjoined twins. Classification:
Thoracopagus - Joined at chest (40%) Xiphopagus/omphalopagus - Joined at abdomen (34%) Pygopagus - Joined at buttocks (18%) Ischiopagus - Joined at ischium (6%) Craniopagus - Joined at head (2%)
Discordant
. Birth weight discrepancies of more than 20-25% are considered discordant. Discordant birth weights occur in 10% of twins.
classification
hydatidiform mole : is the most common form of gestational trophoblastic neoplasia it can behave in a malignant or benign fashion, invasive mole (chorioadenoma destruens), choriocarcinoma, and placental site trophoblastic tumor (PSTT).
Clinical course
In 80% of patients with a benign hydatidiform mole, serum HCG titers steadily drop to normal within 8-12 weeks after evacuation of the molar pregnancy. In the other 20% of patients with a malignant hydatidiform mole, serum HCG titers either rise or plateau.
staging
Stage I Confined to the uterus Stage II Limited to the genital structures Stage III Lung metastases Stage IV Other metastases
Physical Exam
a positive pregnancy test result occurs in the absence of a fetus. vesicles in the vagina is diagnostic Enlarged ovaries secondary to theca lutein cysts are found in up to 20% of cases.
The cysts regress after evacuation of the hydatidiform mole for 12 weeks.
Cause
A hydatidiform mole occurs when a haploid sperm fertilizes an egg that has no maternal chromosomes and then duplicates its chromosomal complement.
Most complete hydatidiform moles are 46,XX, and all the chromosomes come from the male. Of hydatidiform moles, 10-15% are 46,XY. This occurs when 2 sperm, 1 carrying an X and the other carrying a Y, fertilize an "empty" egg.
Partial moles are 69,XXY, and 2 sets of chromosomes are of paternal origin.
Medical care1
Emergency department care involves : starting intravenous (IV) fluids (crystalloids) sending blood for type and antibody screen Rh-negative patients should receive antiRhD immune globulin, such as RhoGAM, if not already immunized
Medical Care2
Patients with benign do not require medical therapy. observing patients with weekly serum HCG titers. Only patients with rising or plateauing titers should be treated with chemotherapy.
Medical care3
Patients with malignant nonmetastatic or metastatic lowrisk GTN are treated with single-agent chemotherapy like MTX or actinomycin D in patients with poor liver function During treatment, the serum HCG titers are monitored every week. One additional course of chemotherapy is administered after a normal serum HCG titer. After 3-4 normal serum HCG titers, the titers are followed once per month for 1 year. A switch from MTX to actinomycin D is made if the patient receiving MTX for nonmetastatic or metastatic low-risk GTN develops rising or plateauing serum HCG titers.
Medical care4
Patients with high-risk metastatic are subdivided into 2 groups:
In patients with a WHO score of less than 8, a combination of MTX, actinomycin D, and cyclophosphamide can be used. This is known as the MAC regimen. This chemotherapeutic regimen is administered every 19-21 days (from day 1 of the previous chemotherapy cycle) until the serum HCG titers normalize.
Medical Care5
Patients with WHO scores of 8 or higher are treated with a combination of etoposide, MTX, and actinomycin D administered in the first week of a 2-week cycle and cyclophosphamide and vincristine (Oncovin) administered in the second week. This is known as the EMA-CO regimen. Two additional courses of EMA-CO or EMA-CE are administered after a normal serum HCG titer in very high-risk patients.
Medical care6
Patients with metastasis to the brain receive whole brain irradiation (3000 cGy) in combination with chemotherapy. Corticosteroids (Decadron) with systemic effect are administered to reduce brain edema. Patients with liver metastasis are considered for liver irradiation (2000 cGy).
Surgical care
The treatment of a hydatidiform mole is evacuation of the uterus by suction and sharp curettage.
To avoid excessive bleeding, oxytocin is administered intravenously at the initiation of the suctioning of the uterine contents. The largest possible suction curet is used, usually a 10F or 12F.
Further Care
Obtain follow-up serum HCG titers : once per week until 3-4 normal values are obtained. Then, obtain them once per month for 6 months. Have patients use reliable contraception, such as oral contraceptives or depot progesterone injections, during the period of follow-up care.
Prognosis1
Nonmetastatic GTN has a cure rate with chemotherapy of close to 100%. Metastatic low-risk gestational trophoblastic neoplasia has a cure rate with chemotherapy of close to 100%. Metastatic high-risk gestational trophoblastic neoplasia has a cure rate with chemotherapy of approximately 75%. After 12 months of normal HCG titers, less than 1% of patients with malignant gestational trophoblastic neoplasia have recurrences.
Prognosis2
The rate of occurrence of a repeat molar pregnancy is approximately 1-2%. The rate of occurrence of a repeat molar pregnancy in a patient with a history of 2 previous hydatidiform moles is approximately 10-20%. The pregnancy rate after chemotherapy with MTX and cyclophosphamide is 80%. Of women treated with EMA-CO, 46% have had at least 1 live birth after chemotherapy. Patients who become pregnant after treatment for GTN should have a pelvic ultrasound early during the pregnancy to confirm that the pregnancy is normal.
PREGNANT DIABETICS
ADAPTATION TO PREGNANCY
In early pregnancy Estrogen and Progesterone stimulate beta cell hyperplasia and increased insulin secretion Glycogenolyis and peripheral utilization increase The net result is relative hypoglycemia
Fasting levels decline by 10 11 mg/dl Postprandial levels rarely exceed 120-140 mg/dl Glucose excursions with meals 30 35 mg/dl Marked increase in insulin levels with feeding
Increased human placental lactogen diabetogenic Increased prolactin insulin resistance Increased cortisol decreased glycogen storage
MATERNAL COMPLICATIONS
Retinopathy Nephropathy Chronic hypertension Preeclampsia
RETINOPATHY
Remains the leading cause of blindness in women ages 24-64 Every patient with pre-gestational diabetes should have a retinal examination in early pregnancy Laser therapy is safe and effective during pregnancy Has a variable course during pregnancy
NEPHROPATHY
Accounts for 1/3 of the deaths in diabetics < 31 Renal findings are present as early as 1-2 years after diagnosis Creatinine clearance may improve in pregnancy due to increased renal blood flow Proteinuria may increase substantially
CHRONIC HYPERTENSION
Should be aggressively controlled ACE inhibitors are contraindicated Calcium channel blockers are probably a reasonable alternative and are safe during pregnancy Increases the incidence of fetal growth restriction and superimposed preeclampsia
PREECLAMPSIA
BP > 140/90 Proteinuria > 300 mg/24 hours or increase in baseline May be difficult to diagnose in the presence of renal disease and chronic HTN 25% incidence of superimposed disease with CHTN
SEVERE PREECLAMPSIA
BP > 180/110 Proteinuria > 5 g/24 hours Lab: elevated LFTs. thrombocytopenia Sxs: headache, epigastric pain, blurred vision Oliguria, pulmonary edema, fetal growth restriction
PREGNANCY COMPLICATIONS
Hydramnios Spontaneous abortions Congenital malformations Macrosomia Diabetic ketoacidosis Neonatal metabolic complications
HYDRAMNIOS
1-2 % in normals and 18% of diabetics Fetal osmotic diuresis is etiologic May also be due to fetal cardiac CNS malformations May be associated with preterm labor ?Associated with level of glycemic control
SPONTANEOUS ABORTIONS
In well controlled patients the rate is similar to the non-diabetic Glycosylated hemoglobin levels are higher in women who have a SAB Higher rates of spontaneous abortion in diabetics with vascular disease
CONGENITAL MALFORMATIONS
Associated with periconceptual glucose control In general the rate is 2-3 x that of the nondiabetic gravida No increase when the father is diabetic Fuel mediated teratogenesis
Fetal cardiac anomalies may be complex CNS Spina Bifida, Anencephaly Caudal regression syndrome Must consider family history of other malformations that are unrelated to DM
MACROSOMIA
Seen more frequently with GDM and IDDM without vascular complications Related to level of 3rd trimester glucose control May occur in up to 25% of diabetics
DIABETIC KETOACIDOSIS
Seen in type I DM Infection, fever, beta agonists are frequent predisposing factors Suspected with +serum ketones and blood glucose levels above 300 Fetal distress is common
PRECONCEPTION COUNSELING
Tight periconceptual control is essential The diabetes should be stable Multidisciplinary team maybe helpful Diabetic education Dietary counseling Assessment of renal function Retinal exam
Fasting blood glucose < 100 mg/dl Pre-meal levels <110 mg/dl Post-meal levels <140 150 mg/dl Avoid wide swings in control Normalize hemoglobin A1C
PREVENTION OF MALFORMATIONS
Normal glucose levels Folic acid supplementation Dose: 4 mg/day from 1 month pre-pregnancy to 12 weeks
FOLIC ACID
All women of reproductive age should consume at least 0.4 mg of folic acid High risk women should consume 4 mg/day This reduces the risk of neural tube defects Newer evidence suggests a lower risk of facial clefting and congenital heart disease as well
Persistent nausea and vomiting Significant maternal infection DKA Poor control/compliance Preterm labor
TIMING OF DELIVERY
Well controlled IDDM: at term Poorly controlled: after documentation of fetal lung maturity If fetal surveillance reassuring, delivery before 39 weeks should be unusual
No breakfast the morning of induction Establish IV with D5/.45% NaCl at 125 cc/hour Capillary blood glucose levels every 1 2 hours Begin continuous infusion of insulin with levels above 120 mg/dl Avoid fluid boluses with D5
SHOULDER DYSTOCIA
BW (g) < 4000 4000-4499 No diabetes(%) 0.1-1.1 1.1-10.0 Diabetes(%) 0.6-3.7 4.9-23.1
> 4500
4.1-22.6
20.0-50.0
NERVE INJURY
Rate varies from 4-40% following shoulder dystocia Most (90%) resolve without sequelae Can occur with EFW < 4000 g Can occur in utero and therefore not preventable by cesarean
Insulin requirements may fall 50% in the 1st 24 hours Little need for treatment if under 200 mg/dl
CONTRACEPTION
Reliable contraception should be offered Low-dose combination OCPs do not significantly impair carbohydrate metabolism Progestin only oral contraceptives appear to accelerate the development of Type 2 DM in women with gestational diabetes Barrier methods and even IUD may be acceptable
Screening
If FBS is 110-126: Then 1 hr 50 gr or 3 hrs 100 gr remember 105 195165---145
Summary
Every practice should adopt a screening strategy, either by historical or laboratory means Screening best between 24-28 weeks Remember to screen post delivery
Bita Hazrati
A PLP case complicated by HTN and GD
24 yrs old G2 P1 L0 D1/ first fetal loss due to preterm c/s delivery ( because of placenta previa) GA on admission 32-33 w CC: LP ( contractions mild/20 seconds D/ 2 in a 10- minute interval) WB: Intact ROM: - ( detected by Fern test) Reduced fetal movement: -
Ph E: PR= 86/min RR:16/min T:36 BP= 140/90 mmHg BS: FBS=112 /10am=134 /4pm=145 /8pm=163
20-30 units total : 2/3 intermediate 1/3 regular Morning: 10 units of NPH- 4 units of regular Afternoon: 4 units of NPH 4 units of regular
FBS is used to adjust evening NPH 2-hr PP (10 am) is used to adjust morning Regular Afternon preprandial (4 pm) is used to adjust morning NPH 2hr PP is used to adjust evening Regular
A-This happens during pregnancy with FBS less than 105 mg/dl. Its treatment is insulin. B-It is a kind of type 2 diabetes. C- All cases will develop overt diabetes within 20 years. D- It happens because of reduced pancreas b cell function. Ans:B
What is the test for a 30 year old 10 wk pregnant woman whose FBS is 85/ 2hr PP is 125?
A- 3 hr GTT B-Repeat of FBS and 2hr PP next week. C-Repeat of FBS and 2hr PP in 24-28 wk. D-Repeat of FBS and 2hr PP in 34 wk. Ans: C
A-poor blood glucose control B-albuminurea C-high creatinine D-chronic HTN Ans: A
A-100 grs oral glucose in 24-28 wk. B-50 grs oral glucose in 20-22 wk. C-75 grs oral glucose in 18-20 wk. D-25 grs oral glucose in 30-32 wk. Ans:A
What is your plan for a 35 wk diabetic pregnant woman whose BP is 140/90 mmHg/ is on 60 units of insulin /FBS=120 mg/dl?
A-increasing the insulin dose B- no treatment C-hospitalization and adjusting insulin dose D-termination of pregnancy Ans:C
What is your management of a 30 yr old 35 wk pregnant woman class R diabetic with severe retinopathy?
A-termination of pregnancy B-Laser photocoagulation C- high dose steroids D-No action is needed now.
Ans:B
A woman with a history of gestation diabetes is asking for follow-up management after her delivery. Her FBS is 108 mg/dl and 2hr PP 135 mg/dl. What do you suggest?
A-repeat of FBS and 2hr PP a year after delivery. B- repeat of FBS and 2hr PP 3 yrs after delivery. C-GTT with 100 grs glucose. D-HbA1C 6 months after delivery. Ans:B
In a woman with overt diabetes , BS is reported to be 130 mg/dl . What do you suggest for her IV infusion?
A- RL and DW5% B-RL and DW5% +insulin 1 unit/hr C-NS +insulin 1.5 units/hr D- NS+insulin 2 units/hr Ans:B
BS below 100 mg/dl : no insulin is needed 100-140 mg/dl:1 unit insulin 140-180 mg/dl:1.5 units insulin 180-220 mg/dl:2 units insulin More than 220 mg/dl:2.5 units insulin